Hormone Therapy Alters Hemostatic and Inflammatory Biomarkers, Increasing CV Risk in Transgender Persons
Platelet activation and coagulation biomarker concentrations were found to be increased in trans women and an inflammatory biomarker was found to be increased in trans men following 12 months of gender-affirming, transdermal hormone therapy, according…
